Micromanagement of the mitochondrial apoptotic pathway by p53

Frontiers in Bioscience

Volumn 16, Issue 2, 2011, Pages 749-758

  Walia, Vijay ^a   Kakar, Smita ^b   Elble, Randolph ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Bcl 2 family; CLIC4; Interaction; Mitochondria; Nontranscriptional; P53; Review

Indexed keywords

CARRIER PROTEIN; CHLORIDE CHANNEL; CLIC4 PROTEIN, HUMAN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL; APOPTOSIS; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; PHYSIOLOGY; PROTEIN TRANSPORT; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHLORIDE CHANNELS; GENES, P53; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79955013102     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3717     Document Type: Article

References (89)

1. M Lacroix, RA Toillon and G Leclercq: p53 and breast cancer, an update. Endocr Relat Cancer 13(2), 293-325 (2006) (Pubitemid 43886660)
2. DR Green and JE Chipuk: p53 and metabolism: Inside the TIGAR. Cell 126(1), 30-2 (2006)
3. M Olivier, R Eeles, M Hollstein, MA Khan, CC Harris and P Hainaut: The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19(6), 607-14 (2002) (Pubitemid 34556481)
4. D Chao and S Korsmeyer: BCL-2 family: regulators of cell death. Annu Rev Immunol 16, 395-419 (1998) (Pubitemid 28183370)
5. A Villunger, EM Michalak, L Coultas, F Mullauer, G Bock, M J Ausserlechner, JM Adams and A Strasser: p53-and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302(5647), 1036-8 (2003) (Pubitemid 37386194)
6. C Caelles, A Helmberg and M Karin: p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370(6486), 220-3 (1994) (Pubitemid 24236778)
7. Y Haupt, S Rowan, E Shaulian, KH Vousden and M Oren: Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev 9(17), 2170-83 (1995)
8. SJ Korsmeyer, MC Wei, M Saito, S Weiler, KJ Oh and PH Schlesinger: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7(12), 1166-73 (2000) (Pubitemid 32042223)
9. E Yang, J Zha, J Jockel, LH Boise, CB Thompson and SJ Korsmeyer: Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80(2), 285-91 (1995)
10. EH Cheng, MC Wei, S Weiler, RA Flavell, TW Mak, T Lindsten and SJ Korsmeyer: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAKmediated mitochondrial apoptosis. Mol Cell 8(3), 705-11 (2001) (Pubitemid 32946946)
11. JK Sax, P Fei, ME Murphy, E Bernhard, SJ Korsmeyer and WS El-Deiry: BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 4(11), 842-9 (2002) (Pubitemid 35331358)
12. J Chipuk and D Green: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18(4), 157-64 (2008)
13. JC Sharpe, D Arnoult and RJ Youle: Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 1644(2-3), 107-13 (2004) (Pubitemid 38281267)
14. G Kroemer: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3(6), 614-20 (1997) (Pubitemid 27264969)
15. MG Annis, EL Soucie, PJ Dlugosz, JA Cruz-Aguado, LZ Penn, B Leber and DW Andrews: Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J 24(12), 2096-103 (2005) (Pubitemid 40961794)
16. PJ Dlugosz, LP Billen, MG Annis, W Zhu, Z Zhang, J Lin, B Leber and DW Andrews: Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J 25(11), 2287-96 (2006) (Pubitemid 44012212)
17. D Hockenbery, G Nunez, C Milliman, RD Schreiber and SJ Korsmeyer: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348(6299), 334-6 (1990) (Pubitemid 120029101)
18. EL Arriola, AM Rodriguez-Lopez, JA Hickman and CM Chresta: Bcl-2 overexpression results in reciprocal downregulation of Bcl-X(L) and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis. Oncogene 18(7), 1457-64 (1999) (Pubitemid 29103633)
19. O Olopade, M Adeyanju, A Safa, F Hagos, R Mick, C Thompson and W Recant: Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3(4), 230-7 (1997)
20. P Athanassiadou, T Dosios, E Petrakakou, A Liossi, C Zerva and P Athanassiades: p53 and bcl-2 protein expression in non-small-cell lung carcinoma. Diagn Cytopathol 19(4), 255-9 (1998) (Pubitemid 28440074)
21. MD Berardo, RM Elledge, C de Moor, GM Clark, CK Osborne and DC Allred: bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 82(7), 1296-302 (1998) (Pubitemid 28155391)
22. QM Chen, J Liu and JB Merrett: Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem J 347(Pt 2), 543-51 (2000) (Pubitemid 30229403)
23. CA Schmitt: Senescence, apoptosis and therapy-cutting the lifelines of cancer. Nat Rev Cancer 3(4), 286-95 (2003) (Pubitemid 37328864)
24. M Sasaki, T Kumazaki, H Takano, M Nishiyama and Y Mitsui: Senescent cells are resistant to death despite low Bcl-2 level. Mech Ageing Dev 122(15), 1695-706 (2001) (Pubitemid 32835217)
25. A Letai, MC Bassik, LD Walensky, MD Sorcinelli, S Weiler and SJ Korsmeyer: Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2(3), 183-92 (2002) (Pubitemid 41043974)
26. X Wu and Y Deng: Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front Biosci 7, d151-6 (2002)
27. T Shibue, K Takeda, E Oda, H Tanaka, H Murasawa, A Takaoka, Y Morishita, S Akira, T Taniguchi and N Tanaka: Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 17(18), 2233-2238 (2003) (Pubitemid 37128638)
28. JR Jeffers, E Parganas, Y Lee, C Yang, J Wang, J Brennan, KH MacLean, J Han, T Chittenden, JN Ihle, PJ McKinnon, JL Cleveland and GP Zambetti: Puma is an essential mediator of p53-dependent and-independent apoptotic pathways. Cancer Cell 4(4), 321-8 (2003) (Pubitemid 37329796)
29. S Cory and JM Adams: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2(9), 647-56 (2002) (Pubitemid 37328916)
30. Y Arima, M Nitta, S Kuninaka, D Zhang, T Fujiwara, Y Taya, M Nakao and H Saya: Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 280(19), 19166-76 (2005) (Pubitemid 41379623)
31. P Dumont, JI Leu, AC Della Pietra, 3rd, DL George and M Murphy: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33(3), 357-65 (2003) (Pubitemid 36278852)
32. S Erster, M Mihara, RH Kim, O Petrenko and UM Moll: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol, 24(15), 6728-41 (2004) (Pubitemid 38944352)
33. S Erster and UM Moll: Stress-induced p53 runs a transcription-independent death program. Biochem Biophys Res Commun 331(3), 843-50 (2005) (Pubitemid 40615515)
34. ND Marchenko, A Zaika and UM Moll: Death signalinduced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 275(21), 16202-12 (2000) (Pubitemid 30366932)
35. M Mihara, S Erster, A Zaika, O Petrenko, T Chittenden, P Pancoska and UM Moll: p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11(3), 577-90 (2003) (Pubitemid 36385115)
36. C Sansome, A Zaika, ND Marchenko and UM Moll: Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 488(3), 110-5 (2001) (Pubitemid 32103581)
37. A Nemajerova, S Wolff, O Petrenko and UM Moll: Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett 579(27), 6079-83 (2005) (Pubitemid 41546250)
38. F Talos, O Petrenko, P Mena and UM Moll: Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res 65(21), 9971-81 (2005) (Pubitemid 41541478)
39. F Essmann, S Pohlmann, B Gillissen, PT Daniel, K Schulze-Osthoff and RU Janicke: Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J Biol Chem 280(44), 37169-77 (2005) (Pubitemid 41587801)
40. J E Chipuk, T Kuwana, L Bouchier-Hayes, NM Droin, DD Newmeyer, M Schuler and DR Green: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303(5660), 1010-4 (2004) (Pubitemid 38209704)
41. S Wolff, S Erster, G Palacios and UM Moll: p53′s mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res 18(7), 733-44 (2008) (Pubitemid 351948223)
42. EC Pietsch, E Perchiniak, AA Canutescu, G Wang, RL Dunbrack and ME Murphy: Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem 283(30), 21294-304 (2008)
43. AM Petros, A Gunasekera, N Xu, ET Olejniczak and SW Fesik: Defining the p53 DNA-binding domain/Bclx(L)-binding interface using NMR. FEBS Lett 559(1-3), 171-4 (2004) (Pubitemid 38186723)
44. JI Leu, P Dumont, M Hafey, ME Murphy and DL George: Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6(5), 443-50 (2004) (Pubitemid 38607505)
45. X Deng, F Gao, T Flagg, J Anderson and WS May: Bcl2′s flexible loop domain regulates p53 binding and survival. Mol Cell Biol 26(12), 4421-34 (2006) (Pubitemid 43877564)
46. K Nakano and KH Vousden: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7(3), 683-94 (2001) (Pubitemid 32706359)
47. T Miyashita and JC Reed: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80(2), 293-9 (1995)
48. E Oda, R Ohki, H Murasawa, J Nemoto, T Shibue, T Yamashita, T Tokino, T Taniguchi and N Tanaka: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288(5468), 1053-8 (2000) (Pubitemid 30324238)
49. Y Shen and T Shenk: Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci U S A 91(19), 8940-4 (1994)
50. G Dewson and R Kluck: Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J Cell Sci 122(Pt 16), 2801-8 (2009)
51. Y Tomita, N Marchenko, S Erster, A Nemajerova, A Dehner, C Klein, H Pan, H Kessler, P Pancoska and UM Moll: WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem 281(13), 8600-6 (2006) (Pubitemid 43847963)
52. ND Marchenko, S Wolff, S Erster, K Becker and UM Moll: Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26(4), 923-34 (2007)
53. B Ahn, D Trinh, L Zajchowski, B Lee, A Elwi and S Kim: Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene 29(8), 1155-66 (2010)
54. C Li, Y Cheng, P Liao and J Kang: Translocation of p53 to mitochondria is regulated by its lipid binding property to anionic phospholipids and it participates in cell death control. Neoplasia 12(2), 150-60 (2010)
55. H Yamaguchi, NT Woods, LG Piluso, HH Lee, J Chen, KN Bhalla, A Monteiro, X Liu, MC Hung and HG Wang: p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem 284(17), 11171-83 (2009)
56. F Mancini, F Gentiletti, M D'Angelo, S Giglio, S Nanni, C D'Angelo, A Farsetti, G Citro, A Sacchi, A Pontecorvi and F Moretti: MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem 279(9), 8169-80 (2004) (Pubitemid 38294708)
57. MC Moroni, ES Hickman, E Lazzerini Denchi, G Caprara, E Colli, F Cecconi, H Muller and K Helin: Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 3(6), 552-8 (2001) (Pubitemid 32536851)
58. XM Sun, M Butterworth, M MacFarlane, W Dubiel, A Ciechanover and GM Cohen: Caspase activation inhibits proteasome function during apoptosis. Mol Cell 14(1), 81-93 (2004) (Pubitemid 38469911)
59. H Sakahira, M Enari and S Nagata: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391(6662), 96-9 (1998) (Pubitemid 28079223)
60. JE Ricci, C Munoz-Pinedo, P Fitzgerald, B Bailly-Maitre, GA Perkins, N Yadava, IE Scheffler, MH Ellisman and DR Green: Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117(6), 773-86 (2004) (Pubitemid 38748893)
61. H Li, H Zhu, CJ Xu and J Yuan: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94(4), 491-501 (1998) (Pubitemid 28391865)
62. BS Sayan, AE Sayan, RA Knight, G Melino and GM Cohen: p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem 281(19), 13566-73 (2006) (Pubitemid 43855270)
63. N Zamzami and G Kroemer: The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2(1), 67-71 (2001) (Pubitemid 33676964)
64. TJ Jentsch, V Stein, F Weinreich and AA Zdebik: Molecular structure and physiological function of chloride channels. Physiol Rev. 82(2), 503-568 (2002) (Pubitemid 34654460)
65. TJ Jentsch: Chloride channels: a molecular perspective. Curr Opin Neurobiol 6(3), 303-10 (1996) (Pubitemid 26235677)
66. E Fernandez-Salas, M Sagar, C Cheng, SH Yuspa and WC Weinberg: p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein. J Biol Chem 274(51), 36488-97 (1999)
67. E Fernández-Salas, K Suh, V Speransky, W Bowers, J Levy, T Adams, K Pathak, L Edwards, D Hayes, C Cheng, A Steven, W Weinberg and S. Yuspa: mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol 22(11), 3610-20 (2002) (Pubitemid 34525205)
68. T Nishizawa, T Nagao, T Iwatsubo, JG Forte and T Urushidani: Molecular cloning and characterization of a novel chloride intracellular channel-related protein, parchorin, expressed in water-secreting cells. J Biol Chem 275(15), 11164-73 (2000) (Pubitemid 30212760)
69. Z Qian, D Okuhara, MK Abe and MR Rosner: Molecular cloning and characterization of a mitogenactivated protein kinase-associated intracellular chloride channel. J Biol Chem 274(3), 1621-7 (1999)
70. BM Tulk, S Kapadia and JC Edwards: CLIC1 inserts from the aqueous phase into phospholipid membranes, where it functions as an anion channel. Am J Physiol Cell Physiol 282(5), C1103-12 (2002) (Pubitemid 34663119)
71. L Ronnov-Jessen, R Villadsen, JC Edwards and OW Petersen: Differential expression of a chloride intracellular channel gene, CLIC4, in transforming growth factor-beta1-mediated conversion of fibroblasts to myofibroblasts. Am J Pathol 161(2), 471-80 (2002) (Pubitemid 36142156)
72. KL Berry, HE Bulow, DH Hall and O Hobert: A C. elegans CLIC-like protein required for intracellular tube formation and maintenance. Science 302(5653), 2134-7 (2003) (Pubitemid 38017948)
73. RJ Morris, Y Liu, L Marles, Z Yang, C Trempus, S Li, JS Lin, JA Sawicki and G Cotsarelis: Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22(4), 411-7 (2004) (Pubitemid 38451371)
74. E Fernandez-Salas, KS Suh, VV Speransky, WL Bowers, JM Levy, T Adams, KR Pathak, LE Edwards, DD Hayes, C Cheng, AC Steven, WC Weinberg and SH Yuspa: mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol 22(11), 3610-20 (2002) (Pubitemid 34525205)
75. KS Suh, M Mutoh, K Nagashima, E Fernandez-Salas, LE Edwards, DD Hayes, JM Crutchley, KG Marin, RA Dumont, JM Levy, C Cheng, S Garfield and SH Yuspa: The organellular chloride channel protein CLIC4/mtCLIC translocates to the nucleus in response to cellular stress and accelerates apoptosis. J Biol Chem 279(6), 4632-41 (2004) (Pubitemid 38199055)
76. KS Suh, M Mutoh, M Gerdes, JM Crutchley, T Mutoh, LE Edwards, RA Dumont, P Sodha, C Cheng, A Glick and SH Yuspa: Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res 65(2), 562-71 (2005)
77. S Kimura, T Maekawa, K Hirakawa, A Murakami and T Abe: Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells. Cancer Res 55(6), 1379-84 (1995)
78. GI Evan, AH Wyllie, CS Gilbert, TD Littlewood, H Land, M Brooks, CM Waters, LZ Penn and DC Hancock: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69(1), 119-28 (1992)
79. J Guo and H Xin: Chinese gene therapy. Splicing out the West? Science 314(5803), 1232-5 (2006) (Pubitemid 44846373)
80. P Jones and S Baylin: The epigenomics of cancer. Cell 128(4), 683-92 (2007) (Pubitemid 46273572)
81. I Roninson: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179(1), 1-14 (2002) (Pubitemid 34195647)
82. G Palacios and U Moll: Mitochondrially targeted wildtype p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25(45), 6133-9 (2006) (Pubitemid 44562412)
83. G Palacios, H Crawford, A Vaseva and U Moll: Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model. Cell Cycle 7(16), 2584-90 (2008)
84. AM Psarra and CE Sekeris: Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions. Biochim Biophys Acta 1787(5), 431-6 (2009)
85. Y Yoshida, H Izumi, T Torigoe, H Ishiguchi, H Itoh, D Kang and K Kohno: P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 63(13), 3729-34 (2003) (Pubitemid 36793059)
86. K Heyne, S Mannebach, E Wuertz, KX Knaup, M Mahyar-Roemer and K Roemer: Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett 578(1-2), 198-202 (2004) (Pubitemid 39576125)
87. KL Sugars, V Budhram-Mahadeo, G Packham and DS Latchman: A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res 29(22), 4530-40 (2001) (Pubitemid 33095013)
88. KS Yee and KH Vousden: Complicating the complexity of p53. Carcinogenesis 26(8), 1317-22 (2005) (Pubitemid 41430092)
89. JP Mathai, M Germain, RC Marcellus and GC Shore: Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 21(16), 2534-44 (2002) (Pubitemid 34438106)